Wei Guo-Xian, Campagna Alexander N, Bobek Libuse A
Department of Oral Biology, School of Dental Medicine, University at Buffalo, SUNY, 3435 Main Street, Buffalo, USA, NY 14214.
Ann Clin Microbiol Antimicrob. 2007 Nov 11;6:14. doi: 10.1186/1476-0711-6-14.
MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity in vitro. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono- and divalent cations, EDTA, pH, and temperature on its antimicrobial activity.
Minimal Inhibitory Concentrations (MICs) were determined using a liquid growth inhibition assay in 96-well microtiter plates. MUC7 12-mer was added at concentrations of 1.56-50 microM. MICs were determined at three endpoints: MIC-0, MIC-1, and MIC-2 (the lowest drug concentration showing 10%, 25% and 50% of growth, respectively). To examine the effect of salts or EDTA, a checkerboard microdilution technique was used. Fractional inhibitory concentration index (FICi) was calculated on the basis of MIC-0. The viability of microbial cells treated with MUC7 12-mer in the presence of sodium or potassium was also determined by killing assay or flow cytometry.
The MICs of MUC7 12-mer against organisms tested ranged from 6.25-50 microM. For C. albicans, antagonism (FICi 4.5) was observed for the combination of MUC7 12-mer and calcium; however, there was synergism (FICi 0.22) between MUC7 12-mer and EDTA, and the synergism was retained in the presence of calcium at its physiological concentration (1-2 mM). No antagonism but additivity or indifference (FICi 0.55-2.5) was observed for the combination of MUC7 12-mer and each K+, Na+, Mg2+, or Zn2+. MUC7 12-mer peptide (at 25 microM) also exerted killing activity in the presence of NaCl, (up to 25 mM for C. albicans and up to 150 mM for E. coli, a physiological concentration of sodium in the oral cavity and serum, respectively) and retained candidacidal activity in the presence of KCl (up to 40 mM). The peptide exhibited higher inhibitory activity against C. albicans at pH 7, 8, and 9 than at pH 5 and 6, and temperature up to 60 degrees C did not affect the activity.
MUC7 12-mer peptide is effective anticandidal agent at physiological concentrations of variety of ions in the oral cavity. These results suggest that, especially in combination with EDTA, it could potentially be applied as an alternative therapeutic agent for the treatment of human oral candidiasis.
MUC7 12肽(RKSYKCLHKRCR)是一种源自人低分子量唾液粘蛋白MUC7的阳离子抗菌肽,在体外具有强大的抗菌活性。为了评估MUC7 12肽的潜在治疗应用,我们研究了单价和二价阳离子、乙二胺四乙酸(EDTA)、pH值和温度对其抗菌活性的影响。
采用96孔微量滴定板中的液体生长抑制试验测定最低抑菌浓度(MIC)。以1.56 - 50微摩尔/升的浓度添加MUC7 12肽。在三个终点测定MIC:MIC - 0、MIC - 1和MIC - 2(分别为显示10%、25%和50%生长的最低药物浓度)。为了研究盐或EDTA的作用,使用棋盘微量稀释技术。基于MIC - 0计算分数抑菌浓度指数(FICi)。还通过杀菌试验或流式细胞术测定在存在钠或钾的情况下用MUC7 12肽处理的微生物细胞的活力。
MUC7 12肽对所测试生物体的MIC范围为6.25 - 50微摩尔/升。对于白色念珠菌,观察到MUC7 12肽与钙的组合具有拮抗作用(FICi为4.5);然而,MUC7 12肽与EDTA之间存在协同作用(FICi为0.22),并且在生理浓度(1 - 2毫摩尔/升)的钙存在下仍保留协同作用。对于MUC7 12肽与每种K +、Na +、Mg2 +或Zn2 +的组合,未观察到拮抗作用,但观察到相加作用或无相互作用(FICi为0.55 - 2.5)。MUC7 12肽(25微摩尔/升)在存在氯化钠的情况下也具有杀菌活性(白色念珠菌可达25毫摩尔/升,大肠杆菌可达150毫摩尔/升,分别为口腔和血清中钠的生理浓度),并且在存在氯化钾(高达40毫摩尔/升)的情况下仍保留杀念珠菌活性。该肽在pH值为7、8和9时对白色念珠菌的抑制活性高于pH值为5和6时,并且高达60摄氏度的温度不影响其活性。
在口腔中多种离子的生理浓度下,MUC7 12肽是有效的抗念珠菌剂。这些结果表明,特别是与EDTA联合使用时,它有可能作为治疗人类口腔念珠菌病的替代治疗剂。